← Leaderboards
Shumway David
Dynport Vaccine Company, Llc
$159,811
Attributed
$159,811
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $91.4K · FY2015–16$100K$75K$50K$25K$0
'15
'16
Funding mix
By agency
NIH$159,811 · 1
By mechanism
N01$159,811 · 1
Top collaborators
No co-investigators on record.
Most similar at Dynport Vaccine Company, Llc
Same institution · by research overlap
- Graig Shockey$9,887,057
- Salama Balume$16,877,312
- David Shumway$6,214,596
- George Saviolakis$1,316,543
- Abraham Kallarkal$10,500
Others in their field
Top investigators on “Therapeutic Agents”
- David Heimbrook · Leidos Biomedical Research, Inc.$386,032,874
- Gregory H Reaman · National Childhood Cancer Foundation$247,684,034
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Sharon A Nachman · Johns Hopkins University$213,337,729
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$208,842,121
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$197,687,122
Research focus
Therapeutic AgentsClinical Trials UnitInfectious Disease TreatmentInvestigationNovel TherapeuticsPhase I Clinical TrialsResistanceAntimicrobial Resistance